Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 5/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | SLC40A1 | Q9NP59 | 7/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3425372 | 0.81 | GLO1 (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL4546341 | 0.79 | TDP1 (0.62) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL379216 | 0.78 | GLO1 (0.59) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL28172351 | 0.77 | TDP1 (0.60) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL31130165 | 0.75 | CYP3A4 (0.61) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL17749155 | 0.75 | GLO1 (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL27947212 | 0.75 | GLO1 (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL7774451 | 0.75 | CYP3A4 (0.61) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL13337941 | 0.75 | MEN1 (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL27938447 | 0.75 | HTT (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6353059-B2 | CROSSLINKING; STABLE MOLECULAR ORIENTATION | SIEMENS AKTIENGESELLSCHAFT (DE) | 2002-03-05 | — | — | US | disclosed |
| US-20010053818-A1 | Polyadducts produced from nonlinear-optically active copolymers and polymerizable nonlinear-optically active monomers | SIEMENS AKTIENGESELLSCHAFT | 2001-12-20 | — | — | US | disclosed |
| US-6174961-B1 | OPTICAL POLYMERS | SIEMENS AKTIENGESELLSCHAFT (DE) | 2001-01-16 | — | — | US | disclosed |
| US-6126867-A | Nonlinear-optically active copolymers, polymer materials produced from them, and electrooptical and photonic components constructed therefrom | SIEMENS AKTIENGESELLSCHAFT (DE) | 2000-10-03 | — | — | US | disclosed |
| EP-0942019-A2 | Non-linear optically active copolymers, polyadducts formed from it and their use in non-linear optical media | SIEMENS AKTIENGESELLSCHAFT (DE) | 1999-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010053818-A1 | Polyadducts produced from nonlinear-optically active copolymers and polymerizable nonlinear-optically active monomers | PARG, PARN, ACMSD | GLO1 380/4885ALOX15 205/4885HTT 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.